Launching September 15, 2026. Join the waitlist
Velri
Medications→Labs→Supplements→Find your path→Why Velri→Learn→Pricing→Where we serve→
Join the waitlist

Medications/NAD+ & energy

47 states + D.C. · Cash-pay

NAD+

Billed at the pharmacy's cost, if prescribed
  • A cellular-energy coenzyme some adults explore with a clinician as part of a longevity and energy goal, if prescribed.
  • Compounded, not FDA approved.
Join the waitlist →

Velri opens September 15, 2026. A prescription is not guaranteed.

NAD+
NAD+ & energy
NAD+
FormInjectable vial or nasal spray, prepared by a compounding pharmacy. Compounded preparations are not FDA approved.
Dispensed byFilled and shipped by an independent licensed pharmacy, if prescribed.
Dosing1- or 3-month supply on a schedule your provider sets, if prescribed.
Compounded medications are not FDA approved.
Compounded medications are prepared by a licensed pharmacy for one patient, are not FDA approved, and are not interchangeable with a brand-name drug.
Illustrative. The pharmacy's packaging may differ. A prescription is never guaranteed.
Who prescribes, who dispenses
Prescribed by
An independent, physician-led Provider Group licensed in your state: TMD of CA PC · Online Medical Care P.C. · TMD of Kansas P.A. · TMD of Texas P.A..
Dispensed by
A licensed U.S. pharmacy, if prescribed.
Velri
Coordinates the membership, routing and follow-up. Velri does not prescribe, does not dispense, and adds no markup; one flat fulfillment fee per order, about $25.
A prescription is required and is never guaranteed. You may opt out of a given Provider Group or pharmacy at any time from your account.
Details
  • GoalNAD+ & energy
  • FormInjectable vial or nasal spray
  • OptionsInjectable and nasal formulations; 1- and 3-month supply
  • AvailabilityAvailable in most states; varies by pharmacy.
  • CostThe pharmacy’s cost, billed separately if prescribed. Velri adds no markup; one flat fulfillment fee per order, about $25.
What you pay
Velri membershipCoordination + support, billed by Velri$79/mo founding
NAD+Per order, if prescribed. Velri adds no markup.pharmacy cost
Provider consultationOne-time, paid to an independent Provider Groupbilled separately
Safety & disclosures

NAD+ given by infusion or injection commonly causes flushing, nausea, headache, and injection-site discomfort, and rapid infusions can cause chest tightness, cramping, or lightheadedness, which is why dosing rate matters. People who are pregnant, breastfeeding, or have significant heart, liver, or kidney conditions should review those with the prescribing provider before use. Long-term safety data for repeated NAD+ therapy is limited, so the risks of ongoing use are not fully established. Contact your provider promptly about chest tightness, severe flushing, or persistent nausea during or after a dose.

Compounded medications are not FDA approved. A prescription is required, is not guaranteed, and is determined by an independent, licensed provider based on your consultation. Velri is a non-clinical company; consultations and prescriptions are provided by independent, licensed Provider Groups, and medications are dispensed by independent, licensed pharmacies. Medication is priced at the pharmacy cost plus one flat Velri fulfillment fee, the same on every product. This page is for general information and is not medical advice.